The results indicated that AIFM3, HSH2D, and PTPN6 were significantly up-regulated, while DCHS1, PTGIS, FLRT2, PCSK5, and CLSTN2 were significantly down-regulated in tumor samples compared with normal samples (Figure 3E). This evidence concerns the gene CLSTN2 and neoplasm.